Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 6;108(12):3321–3332. doi: 10.3324/haematol.2023.283426

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2023 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 3. — Difference in overall survival by diagnosis, age, spleen size and marrow blasts in the total cohort of 120 patients. (A) Overall survival (OS) by diagnosis entities of chronic myelomonocytic leukemia (CMML), myelodysplastic/myeloproliferative overlap neoplasm (MDS/MPN) with neutrophilia (MDS/MPN-N), MDS/MPN not otherwise specified (MDS/MPN-NOS), and MDS/MPN with SF3B1 mutation and thrombocytosis (MDS/MPN-SF3B1-T). (B) OS by patient age at hematopoietic cell transplantation (HCT). (C) OS by spleen size at HCT. (D) OS by bone marrow blast percentage.